Deprescribing on hemodialysis feasible; but challenges remain
A protocol for deprescribing inappropriate medications for patients on hemodialysis was feasible and well received, according to study data.
However, nephrologists who participated in the study said the deprescribing process may be difficult to integrate into their clinical workflow.
Inappropriate medications, such as gabapentinoids and muscle relaxants, are commonly prescribed to older adults on hemodialysis but can lead to adverse events, such as falls, extreme drowsiness, confusion, hospitalization and mortality, Rasheeda Hall, MD, MBA, MHS, associate professor of medicine and population